National Breast Cancer Foundation, INC. Breast Cancer Facts. http://www.nationalbreastcancer.org/breast-cancer-facts
American Cancer Society: breast cancer facts and figures 2016–2017. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html
Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–52.
Article
PubMed
CAS
Google Scholar
Lewis-Wambi JS, Jordan VC. Treatment of postmenopausal breast cancer with Selective Estrogen Receptor Modulators (SERMs). Breast Dis. 2005;24:93–105.
Article
PubMed
CAS
Google Scholar
Hawkins MB, Thornton JW, Crews D, Skipper JK, Dotte A, Thomas P. Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts. Proc Natl Acad Sci U S A. 2000;97(20):10751–6.
Article
PubMed
PubMed Central
CAS
Google Scholar
Gronemeyer H. Transcription activation by estrogen and progesterone receptors. Annu Rev Genet. 1991;25:89–123.
Article
PubMed
CAS
Google Scholar
Pettersson K, Grandien K, Kuiper GG, Gustafsson JA. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol. 1997;11(10):1486–96.
PubMed
CAS
Google Scholar
Cowley SM, Hoare S, Mosselman S, Parker MG. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem. 1997;272(32):19858–62.
Article
PubMed
CAS
Google Scholar
Tremblay GB, Tremblay A, Labrie F, Giguere V. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol. 1999;19(3):1919–27.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wu WF, Tan XJ, Dai YB, Krishnan V, Warner M, Gustafsson JA. Targeting estrogen receptor beta in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2013;110(9):3543–8.
Article
PubMed
PubMed Central
Google Scholar
Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer. 2011;11(8):597–608.
Article
PubMed
CAS
Google Scholar
Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD. Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer. 1989;59(1):119–25.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology. 2001;142(9):4120–30.
Article
PubMed
PubMed Central
CAS
Google Scholar
Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 2004;64(1):423–8.
Article
PubMed
CAS
Google Scholar
Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci U S A. 2004;101(6):1566–71.
Article
PubMed
PubMed Central
CAS
Google Scholar
Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, et al. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A. 2003;100(16):9614–9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sun P, Wei L, Denkert C, Lichtenegger W, Sehouli J. The orphan nuclear receptors, estrogen receptor-related receptors: their role as new biomarkers in gynecological cancer. Anticancer Res. 2006;26(2C):1699–706.
PubMed
CAS
Google Scholar
Giguere V. Orphan nuclear receptors: from gene to function. Endocr Rev. 1999;20(5):689–725.
PubMed
CAS
Google Scholar
Enmark E, Gustafsson JA. Orphan nuclear receptors--the first eight years. Mol Endocrinol. 1996;10(11):1293–307.
PubMed
CAS
Google Scholar
Zhang Z, Chen K, Shih JC, Teng CT. Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. Mol Endocrinol. 2006;20(7):1547–61.
Article
PubMed
CAS
Google Scholar
Lu D, Kiriyama Y, Lee KY, Giguere V. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res. 2001;61(18):6755–61.
PubMed
CAS
Google Scholar
Giguere V, Yang N, Segui P, Evans RM. Identification of a new class of steroid hormone receptors. Nature. 1988;331(6151):91–4.
Article
PubMed
CAS
Google Scholar
Eudy JD, Yao S, Weston MD, Ma-Edmonds M, Talmadge CB, Cheng JJ, Kimberling WJ, Sumegi J. Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of usher syndrome type IIa at 1q41. Genomics. 1998;50(3):382–4.
Article
PubMed
CAS
Google Scholar
Hong H, Yang L, Stallcup MR. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J Biol Chem. 1999;274(32):22618–26.
Article
PubMed
CAS
Google Scholar
Chen F, Zhang Q, McDonald T, Davidoff MJ, Bailey W, Bai C, Liu Q, Caskey CT. Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCR. Gene. 1999;228(1–2):101–9.
Article
PubMed
CAS
Google Scholar
Johnston SD, Liu X, Zuo F, Eisenbraun TL, Wiley SR, Kraus RJ, Mertz JE. Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. Mol Endocrinol. 1997;11(3):342–52.
PubMed
CAS
Google Scholar
Vanacker JM, Pettersson K, Gustafsson JA, Laudet V. Transcriptional targets shared by estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta. EMBO J. 1999;18(15):4270–9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bonnelye E, Vanacker JM, Dittmar T, Begue A, Desbiens X, Denhardt DT, Aubin JE, Laudet V, Fournier B. The ERR-1 orphan receptor is a transcriptional activator expressed during bone development. Mol Endocrinol. 1997;11(7):905–16.
Article
PubMed
CAS
Google Scholar
Sladek R, Bader JA, Giguere V. The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme a dehydrogenase gene. Mol Cell Biol. 1997;17(9):5400–9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev. 2008;29(6):677–96.
Article
PubMed
CAS
Google Scholar
Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell. 2006;126(4):789–99.
Article
PubMed
CAS
Google Scholar
Vega RB, Kelly DP. A role for estrogen-related receptor alpha in the control of mitochondrial fatty acid beta-oxidation during brown adipocyte differentiation. J Biol Chem. 1997;272(50):31693–9.
Article
PubMed
CAS
Google Scholar
Huss JM, Imahashi K, Dufour CR, Weinheimer CJ, Courtois M, Kovacs A, Giguere V, Murphy E, Kelly DP. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab. 2007;6(1):25–37.
Article
PubMed
CAS
Google Scholar
Pettersson K, Svensson K, Mattsson R, Carlsson B, Ohlsson R, Berkenstam A. Expression of a novel member of estrogen response element-binding nuclear receptors is restricted to the early stages of chorion formation during mouse embryogenesis. Mech Dev. 1996;54(2):211–23.
Article
PubMed
CAS
Google Scholar
Collin RW, Kalay E, Tariq M, Peters T, van der Zwaag B, Venselaar H, Oostrik J, Lee K, Ahmed ZM, Caylan R, et al. Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35. Am J Hum Genet. 2008;82(1):125–38.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yu S, Wong YC, Wang XH, Ling MT, Ng CF, Chen S, Chan FL. Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer. Oncogene. 2008;27(23):3313–28.
Article
PubMed
CAS
Google Scholar
Sengupta D, Bhargava DK, Dixit A, Sahoo BS, Biswas S, Biswas G, Mishra SK. ERRbeta signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells. Br J Cancer. 2014;110(8):2144–58.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kleiner HE, Krishnan P, Tubbs J, Smith M, Meschonat C, Shi R, Lowery-Nordberg M, Adegboyega P, Unger M, Cardelli J, et al. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. J Exp Clin Cancer Res. 2009;28:5.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH, Petersen OW, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2007;1(1):84–96.
Article
PubMed
PubMed Central
CAS
Google Scholar
Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003;30(3):256–68.
Article
PubMed
CAS
Google Scholar
Chaudhary S, Madhukrishna B, Adhya AK, Keshari S, Mishra SK. Overexpression of caspase 7 is ERalpha dependent to affect proliferation and cell growth in breast cancer cells by targeting p21(Cip). Oncogenesis. 2016;5:e219.
Article
PubMed
PubMed Central
CAS
Google Scholar
Strauss WM. Preparation of genomic DNA from mammalian tissue. Current protocols in immunology. 2001;Chapter 10:Unit 10 12.
Google Scholar
Listerman I, Sapra AK, Neugebauer KM. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat Struct Mol Biol. 2006;13(9):815–22.
Article
PubMed
CAS
Google Scholar
Truax AD, Greer SF. ChIP and re-ChIP assays: investigating interactions between regulatory proteins, histone modifications, and the DNA sequences to which they bind. Methods Mol Biol. 2012;809:175–88.
Article
PubMed
CAS
Google Scholar
Tourigny A, Charbonneau F, Xing P, Boukrab R, Rousseau G, St-Arnaud R, Brezniceanu ML. CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation. PLoS One. 2012;7(10):e48652.
Article
PubMed
PubMed Central
CAS
Google Scholar
Heckler MM, Zeleke TZ, Divekar SD, Fernandez AI, Tiek DM, Woodrick J, Farzanegan A, Roy R, Uren A, Mueller SC, et al. Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRbeta2) splice variant in breast cancer. Oncotarget. 2016;7(30):47201–20.
Article
PubMed
PubMed Central
Google Scholar
Chanrion M, Negre V, Fontaine H, Salvetat N, Bibeau F, Mac Grogan G, Mauriac L, Katsaros D, Molina F, Theillet C, et al. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. Clin Cancer Res. 2008;14(6):1744–52.
Article
PubMed
PubMed Central
CAS
Google Scholar
Tanida T, Matsuda KI, Yamada S, Hashimoto T, Kawata M. Estrogen-related receptor beta reduces the subnuclear mobility of estrogen receptor alpha and suppresses estrogen-dependent cellular function. J Biol Chem. 2015;290(19):12332–45.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mandal S, Davie JR. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells. J Cell Physiol. 2010;224(1):28–32.
PubMed
CAS
Google Scholar
Duffy MJ. Estrogen receptors: role in breast cancer. Crit Rev Clin Lab Sci. 2006;43(4):325–47.
Article
PubMed
CAS
Google Scholar
Felzen V, Hiebel C, Koziollek-Drechsler I, Reissig S, Wolfrum U, Kogel D, Brandts C, Behl C, Morawe T. Estrogen receptor alpha regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function. Cell Death Dis. 2015;6:e1812.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bombail V, MacPherson S, Critchley HO, Saunders PT. Estrogen receptor related beta is expressed in human endometrium throughout the normal menstrual cycle. Hum Reprod. 2008;23(12):2782–90.
Article
PubMed
PubMed Central
CAS
Google Scholar
van den Berg DL, Zhang W, Yates A, Engelen E, Takacs K, Bezstarosti K, Demmers J, Chambers I, Poot RA. Estrogen-related receptor beta interacts with Oct4 to positively regulate Nanog gene expression. Mol Cell Biol. 2008;28(19):5986–95.
Article
PubMed
PubMed Central
CAS
Google Scholar
Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia. 1998;3(1):49–61.
Article
PubMed
CAS
Google Scholar
Tamrazi A, Carlson KE, Daniels JR, Hurth KM, Katzenellenbogen JA. Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate. Mol Endocrinol. 2002;16(12):2706–19.
Article
PubMed
CAS
Google Scholar
Laidlaw IJ, Clarke RB, Howell A, Owen AW, Potten CS, Anderson E. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology. 1995;136(1):164–71.
Article
PubMed
CAS
Google Scholar
Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001;29(14):2905–19.
Article
PubMed
PubMed Central
CAS
Google Scholar
Petz LN, Nardulli AM. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor a promoter. Mol Endocrinol. 2000;14(7):972–85.
Article
PubMed
CAS
Google Scholar
Dahlman-Wright K, Qiao Y, Jonsson P, Gustafsson JA, Williams C, Zhao C. Interplay between AP-1 and estrogen receptor alpha in regulating gene expression and proliferation networks in breast cancer cells. Carcinogenesis. 2012;33(9):1684–91.
Article
PubMed
CAS
Google Scholar
Zhang CC, Krieg S, Shapiro DJ. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol Endocrinol. 1999;13(4):632–43.
Article
PubMed
CAS
Google Scholar
Barnum KJ, O'Connell MJ. Cell cycle regulation by checkpoints. Methods Mol Biol. 2014;1170:29–40.
Article
PubMed
PubMed Central
CAS
Google Scholar
Mandal M, Bandyopadhyay D, Goepfert TM, Kumar R. Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK). Oncogene. 1998;16(2):217–25.
Article
PubMed
CAS
Google Scholar
Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, Medema RH. p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem. 2000;275(39):30638–43.
Article
PubMed
CAS
Google Scholar
Abbas T, Jha S, Sherman NE, Dutta A. Autocatalytic phosphorylation of CDK2 at the activating Thr160. Cell Cycle. 2007;6(7):843–52.
Article
PubMed
CAS
Google Scholar
Cayrol C, Knibiehler M, Ducommun B. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene. 1998;16(3):311–20.
Article
PubMed
CAS
Google Scholar
Morishita A, Masaki T, Yoshiji H, Nakai S, Ogi T, Miyauchi Y, Yoshida S, Funaki T, Uchida N, Kita Y, et al. Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Hepatology. 2004;40(3):677–86.
Article
PubMed
CAS
Google Scholar
Bianco S, Lanvin O, Tribollet V, Macari C, North S, Vanacker JM. Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. J Biol Chem. 2009;284(35):23286–92.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yu S, Wang X, Ng CF, Chen S, Chan FL. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Cancer Res. 2007;67(10):4904–14.
Article
PubMed
CAS
Google Scholar
Hurd C, Khattree N, Alban P, Nag K, Jhanwar SC, Dinda S, Moudgil VK. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. J Biol Chem. 1995;270(48):28507–10.
Article
PubMed
CAS
Google Scholar
Hurd C, Dinda S, Khattree N, Moudgil VK. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. Oncogene. 1999;18(4):1067–72.
Article
PubMed
CAS
Google Scholar
Hurd C, Khattree N, Dinda S, Alban P, Moudgil VK. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Oncogene. 1997;15(8):991–5.
Article
PubMed
CAS
Google Scholar
Spillman MA, Bowcock AM. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene. 1996;13(8):1639–45.
PubMed
CAS
Google Scholar
Gudas JM, Nguyen H, Li T, Cowan KH. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res. 1995;55(20):4561–5.
PubMed
CAS
Google Scholar
Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID, et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science. 1999;284(5418):1354–6.
Article
PubMed
CAS
Google Scholar
Liu G, Schwartz JA, Brooks SC. Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Res. 2000;60(7):1810–4.
PubMed
CAS
Google Scholar
Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, Der CJ, et al. RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem. 2001;276(45):42259–67.
Article
PubMed
CAS
Google Scholar